Grifols (GIKLY) Beginning Cash Balance (2011 - 2020)
Grifols (GIKLY) posted Beginning Cash Balance of $819.1 million for Q1 2020, down 28.42% quarter-over-quarter from $1.1 billion in Q4 2019, and down 30.29% year-on-year from $1.2 billion in Q2 2019.
Grifols (GIKLY) Beginning Cash Balance (2011 - 2020) Analysis & Trends
Grifols (GIKLY) has reported Beginning Cash Balance for 8 consecutive years, with $819.1 million the latest figure, recorded in Q1 2020.
- Beginning Cash Balance for Q1 2020 came in at $819.1 million, down 30.29% year-over-year; the trailing twelve-month figure through Mar 2020 was $4.2 billion (up 26.69% YoY), and the FY2019 annual result was $1.1 billion, up 13.09% from the prior year.
- Beginning Cash Balance was $819.1 million for Q1 2020 at Grifols, down from $1.1 billion in the prior quarter.
- Over five years, Beginning Cash Balance peaked at $1.2 billion in Q1 2019 and troughed at $819.1 million in Q1 2020.
- Average Beginning Cash Balance over 4 years is $1.0 billion, with a median of $1.1 billion recorded in 2017.
- Year-over-year, Beginning Cash Balance increased 14.22% in 2018 and sank 30.29% in 2020.
- Over 4 years, Beginning Cash Balance stood at $1.1 billion in 2017, then decreased by 3.98% to $1.0 billion in 2018, then increased by 13.09% to $1.1 billion in 2019, then dropped by 28.42% to $819.1 million in 2020.
- Per Business Quant data, the three most recent Beginning Cash Balance figures were $819.1 million in Q1 2020, $1.1 billion in Q4 2019, and $1.2 billion in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Grifols | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 819.10 Mn |
| Mar 31, 2020 | 819.10 Mn |
| Dec 31, 2019 | 1.14 Bn |
| Dec 31, 2019 | 1.14 Bn |
| Mar 31, 2019 | 1.18 Bn |
| Mar 31, 2019 | 1.18 Bn |
| Dec 31, 2018 | 1.01 Bn |
| Dec 31, 2018 | 1.01 Bn |
| Mar 31, 2018 | 1.09 Bn |
| Mar 31, 2018 | 1.09 Bn |
| Dec 31, 2017 | 1.05 Bn |
| Dec 31, 2017 | 1.05 Bn |
| Mar 31, 2017 | 953.55 Mn |
| Mar 31, 2017 | 953.55 Mn |
| Mar 31, 2015 | 1.22 Bn |
| Mar 31, 2015 | 1.22 Bn |
| Sep 30, 2014 | 939.81 Mn |
| Sep 30, 2014 | 939.81 Mn |
| Jun 30, 2014 | -971.38 Mn |
| Jun 30, 2014 | -971.38 Mn |